Literature DB >> 10577525

Improvement of visual function with glare testing after photorefractive keratectomy and radial keratotomy.

B S Boxer Wachler1, D S Durrie, K K Assil, R R Krueger.   

Abstract

PURPOSE: To evaluate the effect of a glare source on visual function in patients after photorefractive keratectomy and radial keratotomy.
METHODS: Thirteen patients (22 eyes) who underwent photorefractive keratectomy and 20 patients (40 eyes) who underwent radial keratotomy were evaluated in this cross-sectional study. LogMAR visual acuity and contrast sensitivity were measured. Pupils were measured with the Rosenbaum card. A halogen/tungsten glare source approximated the luminance of headlights of an oncoming car at 100 feet.
RESULTS: In the photorefractive keratectomy and radial keratotomy groups, pupils were significantly smaller (P<.01) and the pupillary clearance of the ablation zone in photorefractive keratectomy and the clear zone in radial keratotomy were significantly larger under the glare condition (P<.01). In the photorefractive keratectomy group, visual acuity and contrast sensitivity under the glare condition were significantly higher than in the no-glare condition (P = .02). In the radial keratotomy group, contrast sensitivity under the glare condition was significantly higher than under the no-glare condition (P = .001 to .003).
CONCLUSIONS: After photorefractive keratectomy or radial keratotomy, the traditional glare source constricted the pupil and partially masked the optical aberrations, which resulted in an improvement in visual function. A "pupil-sparing" aberration test is needed for evaluation of visual function after refractive surgery.

Entities:  

Mesh:

Year:  1999        PMID: 10577525     DOI: 10.1016/s0002-9394(99)00219-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  1 in total

1.  Photophobia measurement in intermittent exotropia using the contrast sensitivity test.

Authors:  Seung Ah Chung; Soolienah Rhiu; Seung Han Han; Jong Bok Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-20       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.